Recent Patents on Inflammation and Allergy Drug Discovery- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details

About Recent Patents on Inflammation and Allergy Drug Discovery

Recent Patents on Inflammation and Allergy Drug Discovery is a journal published by Bentham Science Publishers B.V.. This journal covers the area[s] related to Drug Discovery, Medicine (miscellaneous), Immunology and Allergy, etc. The coverage history of this journal is as follows: 2007-2020. The rank of this journal is 4975. This journal's impact score, h-index, and SJR are 0.00, 0, and 0.879, respectively. The ISSN of this journal is/are as follows: 1872213X, 22122710.

The best quartile of Recent Patents on Inflammation and Allergy Drug Discovery is Q1. This journal has received a total of 0 citations during the last three years (Preceding 2021).

Recent Patents on Inflammation and Allergy Drug Discovery Impact Score 2021-2022

The latest impact score (IS) of the Recent Patents on Inflammation and Allergy Drug Discovery is 0.00. It is computed in the year 2022 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Prediction of Recent Patents on Inflammation and Allergy Drug Discovery Impact Score 2022

Impact Score 2021 of Recent Patents on Inflammation and Allergy Drug Discovery is 0.00. If a similar upward trend continues, IS may increase in 2022 as well.

Recent Patents on Inflammation and Allergy Drug Discovery h-index

 

The h-index of Recent Patents on Inflammation and Allergy Drug Discovery is 0. By definition of the h-index, this journal has at least 0 published articles with more than 0 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.

Recent Patents on Inflammation and Allergy Drug Discovery ISSN

The International Standard Serial Number (ISSN) of Recent Patents on Inflammation and Allergy Drug Discovery is/are as follows: 1872213X, 22122710.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Recent Patents on Inflammation and Allergy Drug Discovery Ranking and SCImago Journal Rank (SJR)

The Recent Patents on Inflammation and Allergy Drug Discovery is ranked 4975 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.879.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Recent Patents on Inflammation and Allergy Drug Discovery Publisher

The publisher of Recent Patents on Inflammation and Allergy Drug Discovery is Bentham Science Publishers B.V.. The publishing house of this journal is located in the United Arab Emirates. Its coverage history is as follows: 2007-2020.

Call For Papers (CFPs)

Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).

Abbreviation

The International Organization for Standardization 4 (ISO 4) abbreviation of Recent Patents on Inflammation and Allergy Drug Discovery is Recent Pat. Inflamm. Allergy Drug Discov.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Recent Pat. Inflamm. Allergy Drug Discov.') can be used for citing, indexing, abstraction, and referencing purposes.

How to publish in Recent Patents on Inflammation and Allergy Drug Discovery

If your area of research or discipline is related to Drug Discovery, Medicine (miscellaneous), Immunology and Allergy, etc., please check the journal's official website to understand the complete publication process.

Acceptance Rate

There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

• Interest/demand of researchers/scientists for publishing in a specific journal/conference.
• The complexity of the peer review process and timeline.
• Time taken from draft submission to final publication.
• Number of submissions received and acceptance slots
• And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/
• Issn.org, https://www.issn.org/
• Scopus, https://www.scopus.com/